IL6 and macrophage activation syndrome: Moreover, transgenic expression of viral IL-6 in mice led to the development of splenomegaly and lymphadenopathy and increased endogenous expression of IL-6 (75), somewhat reminiscent of the IL-6-transgenic mouse model of MAS (76).